Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effects of Otago Exercise Program Vs Blind Folded Exercise on Falls, Balance and Quality of Life in Geriatric Population.

28 août 2026 mis à jour par: Ibadat International University, Islamabad

As people age, maintaining balance can become more difficult, which increases the risk of dangerous falls. This clinical study aims to compare two different physical therapy programs to see which one is more effective at improving balance, reducing the frequency of falls, and enhancing the overall quality of life for older adults (aged 60 and older).

The first program is the Otago Exercise Program (OEP), which is a well-established, widely used routine focused on leg strengthening and active balance exercises. The second program is Blindfolded Exercise (BFE), which uses a safety harness or support bars while participants perform balance movements with their eyes covered. Temporarily removing vision forces the brain and body to rely more heavily on inner-ear balance systems (vestibular) and muscle/joint awareness (proprioception) to stay upright.

A total of 40 participants will be randomly assigned to one of these two exercise groups. Both groups will attend 30- to 45-minute physical therapy sessions, 3 times a week, for a total of 6 weeks. Researchers will assess participants' balance, walking speed, and overall quality of life at the beginning, middle, and end of the study to determine if sensory-deprived training (blindfolded) or muscle-strengthening training (Otago) offers better protection against falls.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

This study is a single-blinded, parallel-group, Randomized Controlled Trial (RCT) designed to compare the clinical efficacy of a strength-and-balance-based motor retraining program against a sensory-reweighting paradigm in community-dwelling older adults. The primary objective is to evaluate and contrast the effects of these distinct therapeutic approaches on postural stability, fall frequency, and health-related quality of life.

Participant Recruitment & Randomization:

Forty (40) participants aged 60 and older who meet the inclusion criteria will be recruited for this study. Eligible participants must have a history of a fall within the last three months, a Berg Balance Scale (BBS) score of 40 or lower, a positive Romberg test, and the ability to perform the Timed Up and Go (TUG) test. Following baseline assessments, participants will be randomly allocated to either Group 1 (Otago Exercise Program) or Group 2 (Blindfolded Exercise) in a 1:1 ratio using the sealed envelope randomization method.

Intervention Protocols:

All participants will undergo a 6-week intervention period consisting of 3 sessions per week, with each session lasting 30 to 45 minutes. Both groups will receive a standardized baseline physical therapy session (including a brief warm-up, heating pads, and light aerobic conditioning) prior to their specialized training:

  • Group 1: Otago Exercise Program (OEP): This progressive program focuses on lower limb muscle strengthening (targeting the quadriceps, hamstrings, gluteus medius, calves, and tibialis anterior) and progressive balance retraining (e.g., heel-to-toe walking, backward walking, and sit-to-stand transitions). Muscle-strengthening exercises will be progressively loaded using ankle weights (ranging from 500g up to 1kg) depending on individual tolerance, while balance activities will advance from supported to unsupported conditions.
  • Group 2: Blindfolded Exercise (BFE): This sensory-reweighting program utilizes temporary visual deprivation via a blindfold to limit visual input during functional balance exercises. Exercises are conducted under strict safety conditions (utilizing support bars, harnesses, and knee stabilizers as needed to prevent falls). The difficulty of the tasks will progress sequentially over the 6 weeks (e.g., transitioning from a supported wide-base stance to an unsupported tandem stance, and eventually to an unsupported single-leg stance, with eyes closed).

Outcome Measures & Assessment:

Clinical outcomes will be measured at three distinct time points: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6). The primary outcomes include:

  • Postural Balance: Assessed using the Berg Balance Scale (BBS).
  • Functional Mobility & Fall Risk: Evaluated using the Timed Up and Go (TUG) test.
  • Health-Related Quality of Life: Measured using the SF-36 health survey.

Statistical Analysis:

Data will be analyzed using SPSS software. Normality of the data will be assessed using the Shapiro-Wilk test. Within-group changes from baseline to post-intervention will be evaluated using paired-sample t-tests (or Wilcoxon signed-rank tests for non-parametric data). Between-group differences will be analyzed using independent-sample t-tests (or Mann-Whitney U tests). A Mixed-Model Analysis of Variance (ANOVA) will be utilized to determine the interaction effects between the groups over the three measurement intervals, with statistical significance set at p < 0.05.

Type d'étude

Interventionnel

Inscription (Réel)

40

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • KPK
      • Peshawar, KPK, Pakistan, 25000
        • Physioworks

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • History of fall within last 3 months.
  • Berg balance should be less than or equal to 40.
  • Patient age 60 and above.
  • Romberg test positive.

Exclusion Criteria:

  • Participants having cognition problems or a language barrier.
  • Physical disability (fracture or amputation).
  • Patient those have Secondary neurological condition (Parkinson's disease, stroke).
  • Previous surgery for last 6 weeks. Unstable Cardiovascular and pulmonary disease.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Otago Exercise Program Group (OEP)
Participants in this group will undergo a structured, progressive muscle-strengthening and balance-retraining program.
A 6-week progressive exercise program performed 3 times per week (30-45 minutes per session). It includes specific lower-limb muscle-strengthening exercises using progressive ankle weights (500g to 1kg) and progressive static/dynamic balance training (e.g., tandem walking, backward walking, sit-to-stand transitions).
Autres noms:
  • standard physical therapy
Expérimental: Blindfolded Exercise Group (BFE)
Participants in this group will undergo a progressive balance training program under temporary visual deprivation using a blindfold.
A 6-week sensory-reweighting balance program performed 3 times per week (30-45 minutes per session) with participants wearing a blindfold to eliminate visual cues. Exercises progress from wide-base supported stances to narrow-base and single-leg unsupported stances, conducted using strict safety measures (e.g., parallel bars, safety harnesses, and knee stabilizers).

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Berg Balance Scale (BBS)
Délai: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A 14-item objective measure designed to assess static balance and fall risk in adult populations. Each item is scored on a 5-point scale ranging from 0 (lowest function) to 4 (highest function), with a maximum total score of 56 points. Lower scores indicate poorer balance and higher fall risk.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
Berg Balance Scale(BBS)
Délai: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A 14-item objective measure designed to assess static balance and fall risk in adult populations. Each item is scored on a 5-point scale ranging from 0 (lowest function) to 4 (highest function), with a maximum total score of 56 points. Lower scores indicate poorer balance and higher fall risk.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Timed Up and Go (TUG) Test
Délai: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A mobility and dynamic balance assessment that measures the time (in seconds) taken by a participant to rise from a standard armchair, walk 3 meters, turn around, walk back, and sit down. Shorter completion times indicate better functional mobility and lower fall risk.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
Quality of Life Assessment Tool SF 36 Model
Délai: Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).
A 36-item self-reported questionnaire used to evaluate health-related quality of life across eight domains: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health. Scores for each domain range from 0 to 100, where higher scores indicate better health state and higher quality of life.
Baseline (Week 0), Mid-intervention (Week 3), and Post-intervention (Week 6).

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

7 mai 2026

Achèvement primaire (Réel)

14 juillet 2026

Achèvement de l'étude (Réel)

14 juillet 2026

Dates d'inscription aux études

Première soumission

23 juillet 2026

Première soumission répondant aux critères de contrôle qualité

28 août 2026

Première publication (Réel)

1 septembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

1 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

28 août 2026

Dernière vérification

1 juillet 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • IIUI/RERC/ADT/2026/05/257

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data (IPD) will not be shared publicly to maintain participant confidentiality and privacy in accordance with institutional review board (IRB) and ethical guidelines. Aggregate study results and outcomes will be made available through peer-reviewed publications.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .